Meeting

In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries

Tuesday, June 25, 2024
Thomas Peter/REUTERS
Speakers
Monique K. Mansoura

Executive Director, Global Health Security and Biotechnology, The MITRE Corporation

Victor Suarez

Colonel (Ret), U.S. Army, Senior Fellow (Visiting), The Council on Strategic Risks; Founder, BluZoneBio

Presider
David P. Fidler

Senior Fellow for Global Health and Cybersecurity, Council on Foreign Relations

Roundtable Series on U.S. Foreign Policy and Global Health

The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.  

Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.

Explore More on United States

Trade

What Are Tariffs?
U.S. Presidents Trump and Biden have both turned to tariffs to support local industries amid economic confrontation with China. Here’s how these taxes work and how they’ve been used historically.

Backgrounder by Andrew Chatzky, Anshu Siripurapu and Noah Berman November 26, 2024 Renewing America

G20 (Group of Twenty)

What Does the G20 Do?
The Group of Twenty, an informal gathering of many of the world’s largest economies, is the premier global forum for discussing economic issues. It is facing continued divisions over trade, climate change, and the war in Ukraine.

Backgrounder by Anshu Siripurapu, Noah Berman and James McBride November 15, 2024

United States

U.S. Disaster Relief at Home and Abroad
The U.S. government responds to scores of disasters each year in coordination with foreign, state, and local partners, but more frequent and severe storms, fires, and floods are straining resources.

Backgrounder by Diana Roy, Amelia Cheatham and Rocio Cara Labrador October 23, 2024

Top Stories on CFR

Donald Trump

Trump’s Executive Orders: What to Expect
President-elect Trump has promised to commence his new term with an expansive array of executive actions, some of which could have immediate effects on U.S. foreign policy.  

In Brief by Jonathan Masters and Diana Roy January 17, 2025

Foreign Policy

The Israel-Hamas Cease-Fire and its Implications
After the Israel-Hamas cease-fire announcement, Steven A. Cook, CFR’s Eni Enrico Mattei Senior Fellow for Middle East and Africa Studies, and I discuss its significance and implications.

Article by Michael Froman January 17, 2025

Technology and Innovation

Why the TikTok Ban Harms U.S. Interests at Home and Abroad
U.S. government officials should quickly declassify information about the national security threat posed by Chinese-owned TikTok or risk huge public backlash and a global loss of stature as a free speech champion.

Expert Brief by Kat Duffy January 17, 2025